Skip to main content
ConductScienceScienceDex

Lon S Schneider

NIH Rank #4376
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1960378Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#4,376
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lon S Schneider. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Lon S Schneider as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG074983-03R01
    Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
    Institute for Molecular Medicine
    $2.2M
    award amount

Award organization

Organizations that administered FY2024 awards listing Lon S Schneider as a PI.

FY2024 award administered by Institute for Molecular Medicine (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Institute for Molecular Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4376
  6. 2024
    Entered Top 25% Nationally
    Ranked #4376
  7. 2025
    $5M Cumulative Funding
  8. 2025
    $10M Cumulative Funding
  9. 2025
    Entered Top 10% Nationally
    Ranked #214
  10. 2025
    Entered Top 5% Nationally
    Ranked #214
  11. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Lon S Schneider.

Michael G Agadjanyan
Institute for Molecular Medicine
4
shared awards
David Sultzer
Institute for Molecular Medicine
3
shared awards
Annie E Hiniker
University of Southern California
2
shared awards
Arthur W Toga
University of Southern California
2
shared awards
Helena Chang Chui
University of Southern California
2
shared awards
Hussein N Yassine
University of Southern California
2
shared awards
Maria P. Aranda
University of Southern California
2
shared awards
Robert Rissman
University of Southern California
2
shared awards
Duygu Tosun-turgut
Institute for Molecular Medicine
1
shared award
James E Galvin
Institute for Molecular Medicine
1
shared award

Explore further

Find collaborators for Lon S Schneider

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →